Hachiouji, Japan

Takeo Deguchi


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):

Title: **Takeo Deguchi: Innovator in Human Arylamine N-Acetyltransferase Research**

Introduction

Takeo Deguchi is a notable inventor based in Hachiouji, Japan, recognized for his contributions to the field of genetics and pharmacology. With one patent to his name, he has made significant strides in the understanding of human arylamine N-acetyltransferase (NAT), a crucial enzyme that plays a role in drug metabolism and the detoxification of harmful substances.

Latest Patents

Deguchi's patent, titled "Methods and kits for identifying human arylamine N-acetyltransferase," involves the identification of polymorphic human NAT genes. Specifically, it details a type 1 NAT gene which includes the 5'-noncoding region base sequence of SEQ ID NO:1 and the coding region base sequence of SEQ ID NO:2. Additionally, the patent describes type 2 and type 3 NAT genes that contain the sequences of SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, and SEQ ID NO:6. The invention also encompasses methods for detecting these polymorphic genes and diagnosing adverse effects resulting from amino-containing aromatic substances.

Career Highlights

Throughout his career, Takeo Deguchi has worked with prominent institutions, including the Tokyo Metropolitan Institute for Neuroscience and Otsuka Pharmaceutical Company, Limited. His work at these organizations has paved the way for advancements in medical research, particularly in understanding genetic variations and their implications in pharmacology.

Collaborations

Deguchi has collaborated with several esteemed colleagues in his field. Notable partners include Moritoshi Kinoshita and Kiyonori Katsuragi, who have played significant roles in advancing research efforts alongside him. Their combined expertise has contributed to meaningful discoveries in the study of NAT and its relevance to human health.

Conclusion

Takeo Deguchi's innovative work in identifying and utilizing human arylamine N-acetyltransferase genes demonstrates his commitment to enhancing scientific knowledge and improving public health outcomes. Through his patent and collaborations, Deguchi continues to influence the landscape of genetic research and its application in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…